183 related articles for article (PubMed ID: 9356201)
1. Experimental kallikrein gene therapy in hypertension, cardiovascular and renal diseases.
Chao J; Chao L
Pharmacol Res; 1997 Jun; 35(6):517-22. PubMed ID: 9356201
[TBL] [Abstract][Full Text] [Related]
2. Human kallikrein gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in Dahl salt-sensitive rats.
Chao J; Zhang JJ; Lin KF; Chao L
Hum Gene Ther; 1998 Jan; 9(1):21-31. PubMed ID: 9458239
[TBL] [Abstract][Full Text] [Related]
3. Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats.
Wang C; Chao L; Chao J
J Clin Invest; 1995 Apr; 95(4):1710-6. PubMed ID: 7535795
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated kallikrein gene delivery reverses salt-induced renal injury in Dahl salt-sensitive rats.
Chao J; Zhang JJ; Lin KF; Chao L
Kidney Int; 1998 Oct; 54(4):1250-60. PubMed ID: 9767541
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy in hypertension: adenovirus-mediated kallikrein gene delivery in hypertensive rats.
Jin L; Zhang JJ; Chao L; Chao J
Hum Gene Ther; 1997 Oct; 8(15):1753-61. PubMed ID: 9358025
[TBL] [Abstract][Full Text] [Related]
6. Kallikrein gene therapy: a new strategy for hypertensive diseases.
Chao J; Chao L
Immunopharmacology; 1997 Jun; 36(2-3):229-36. PubMed ID: 9228551
[TBL] [Abstract][Full Text] [Related]
7. Kallikrein gene therapy in newborn and adult hypertensive rats.
Chao J; Yang Z; Jin L; Lin KF; Chao L
Can J Physiol Pharmacol; 1997 Jun; 75(6):750-6. PubMed ID: 9276159
[TBL] [Abstract][Full Text] [Related]
8. Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure.
Wolf WC; Yoshida H; Agata J; Chao L; Chao J
Kidney Int; 2000 Aug; 58(2):730-9. PubMed ID: 10916096
[TBL] [Abstract][Full Text] [Related]
9. Systemic and portal vein delivery of human kallikrein gene reduces blood pressure in hypertensive rats.
Chao J; Jin L; Chen LM; Chen VC; Chao L
Hum Gene Ther; 1996 May; 7(8):901-11. PubMed ID: 8727504
[TBL] [Abstract][Full Text] [Related]
10. Human adrenomedullin gene delivery protects against cardiac hypertrophy, fibrosis, and renal damage in hypertensive dahl salt-sensitive rats.
Zhang JJ; Yoshida H; Chao L; Chao J
Hum Gene Ther; 2000 Sep; 11(13):1817-27. PubMed ID: 10986555
[TBL] [Abstract][Full Text] [Related]
11. Kallikrein gene delivery attenuates hypertension and cardiac hypertrophy and enhances renal function in Goldblatt hypertensive rats.
Yayama K; Wang C; Chao L; Chao J
Hypertension; 1998 May; 31(5):1104-10. PubMed ID: 9576121
[TBL] [Abstract][Full Text] [Related]
12. Recombinant adeno-associated virus-mediated kallikrein gene therapy reduces hypertension and attenuates its cardiovascular injuries.
Wang T; Li H; Zhao C; Chen C; Li J; Chao J; Chao L; Xiao X; Wang DW
Gene Ther; 2004 Sep; 11(17):1342-50. PubMed ID: 15175642
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated delivery of human kallistatin gene reduces blood pressure of spontaneously hypertensive rats.
Chen LM; Chao L; Chao J
Hum Gene Ther; 1997 Feb; 8(3):341-7. PubMed ID: 9048201
[TBL] [Abstract][Full Text] [Related]
14. Muscle delivery of human kallikrein gene reduces blood pressure in hypertensive rats.
Xiong W; Chao J; Chao L
Hypertension; 1995 Apr; 25(4 Pt 2):715-9. PubMed ID: 7721421
[TBL] [Abstract][Full Text] [Related]
15. Human adrenomedullin gene delivery protects against cardiovascular remodeling and renal injury.
Chao J; Kato K; Zhang JJ; Dobrzynski E; Wang C; Agata J; Chao L
Peptides; 2001 Nov; 22(11):1731-7. PubMed ID: 11754958
[TBL] [Abstract][Full Text] [Related]
16. Atrial natriuretic peptide gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in salt-sensitive rats.
Lin KF; Chao J; Chao L
Hum Gene Ther; 1998 Jul; 9(10):1429-38. PubMed ID: 9681414
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated kallikrein gene delivery reduces aortic thickening and stroke-induced death rate in Dahl salt-sensitive rats.
Zhang JJ; Chao L; Chao J
Stroke; 1999 Sep; 30(9):1925-31; discussion 1931-2. PubMed ID: 10471446
[TBL] [Abstract][Full Text] [Related]
18. Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress.
Zhang JJ; Bledsoe G; Kato K; Chao L; Chao J
Kidney Int; 2004 Aug; 66(2):722-32. PubMed ID: 15253727
[TBL] [Abstract][Full Text] [Related]
19. Human kallikrein gene delivery protects against gentamycin-induced nephrotoxicity in rats.
Murakami H; Yayama K; Chao L; Chao J
Kidney Int; 1998 May; 53(5):1305-13. PubMed ID: 9573546
[TBL] [Abstract][Full Text] [Related]
20. Intramuscular delivery of rAAV-mediated kallikrein gene reduces hypertension and prevents cardiovascular injuries in model rats.
Wang T; Hou LB; Liu ZJ; Wang Y; Chen CL; Xiao X; Wang DW
Acta Pharmacol Sin; 2007 Dec; 28(12):1898-906. PubMed ID: 18031602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
